Telix Pharmaceuticals Limited Noncurrent Restricted Cash And Cash Equivalents
Telix Pharmaceuticals Limited (TLPPF) had Noncurrent Restricted Cash And Cash Equivalents of $33.42 million as of 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes
ifrs-full:NoncurrentRestrictedCashAndCashEquivalents · last filed 2026-02-20
- 2024-12-31: Noncurrent Restricted Cash And Cash Equivalents 50.00M AUD.
- 2023-12-31: Noncurrent Restricted Cash And Cash Equivalents 0.00 AUD.
AUD
| Period end | Noncurrent Restricted Cash And Cash Equivalents |
|---|---|
| 2024-12-31 | 50.00M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 0.00 AUD 20-F · filed 2025-02-24 |
USD
| Period end | Noncurrent Restricted Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $33.42M 20-F · filed 2026-02-20 |
| 2024-12-31 | $30.97M 20-F · filed 2026-02-20 |